The design, make, test, and analyze cycle (DMTA), which drives early-stage drug discovery, requires workflows and automated methods for sample storage and tracking, low volume dispensing of ...
Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago as part of a groundbreaking study. Today, these samples rest in a tucked-away ...
BURLINGTON, Mass., Jan. 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale ...
The CryoArc™ Pico Automated Storage System from Azenta Life Sciences is designed to bring automated cryogenic sample management to biobanking, clinical research, and cell and gene therapy laboratories ...
Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the “Ultra”), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to ...
As research programs expand across sites and disciplines, the limitations of traditional sample storage practices become more apparent. Disconnected records, overcrowded freezers, and unclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results